Anna Conen

2.5k citations
73 papers · 1.8k · 1 hit paper · h-index 23

Impact in

    • COVID-19 Clinical Research Studies
    • Antifungal resistance and susceptibility
    • HIV/AIDS Research and Interventions
    • Bacterial Infections and Vaccines

Papers in

    • COVID-19 Clinical Research Studies 12
    • Antifungal resistance and susceptibility 10
    • HIV/AIDS Research and Interventions 4
    • Infective Endocarditis Diagnosis and Management 8
    • HIV, Drug Use, Sexual Risk 3

Anna Conen

69 papers receiving 1.7k citations

Anna Conen's Hit Papers

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses 2022 · 290 citations
2900+1+2Years since publication50100150200250

Peers

Anna Conen
Comparison fields: 5 of 98
  • Infectious Diseases 663
  • Microbiology 135
  • Hepatology 149
  • Critical Care and Intensive Care Medicine 69
  • Epidemiology 381
Replace Lurdes Santos with:
Lurdes Santos Portugal
Liana Signorini Italy
Haluk Eraksoy Türkiye
Henri Laurichesse France
Pierre Fillâtre France
Antonio Mastroianni Italy
Joseph R. Lentino United States
Nahit Çakar Türkiye
M. Rosenheim France
Stephen Aronoff United States
Anna Conen relative to Lurdes Santos Portugal Lurdes Santos's profile →
Citations per field
00.5×2×3.2×
Lurdes Santos · 1×
Citations per year

Countries citing papers authored by Anna Conen

Since Specialization
Citations

This map shows the geographic impact of Anna Conen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Conen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Conen more than expected).

Fields of papers citing papers by Anna Conen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Conen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Conen. The network helps show where Anna Conen may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Conen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Conen Line = papers co-authored together Anna Conen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Hit paper breakdown →
2022290
2 2008207
3 202082
4 201964
5 201356
6 201555
7 201654
8 201151
9 201350
10 202048
11 200847
12 202043
13 200934
14 201033
15 202132
16 201831
17 202131
18 202231
19 201730
20 202129

About Anna Conen

Anna Conen is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Surgery and Critical Care and Intensive Care Medicine, having authored 73 papers that have together received 1.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (12 papers), Antifungal resistance and susceptibility (10 papers), Infective Endocarditis Diagnosis and Management (8 papers), Hepatitis C virus research (7 papers), HIV/AIDS Research and Interventions (4 papers), Orthopedic Infections and Treatments (3 papers), HIV, Drug Use, Sexual Risk (3 papers) and Surgical site infection prevention (3 papers). The work is most often cited by research in Infectious Diseases (663 citations), Microbiology (135 citations), Hepatology (149 citations), Critical Care and Intensive Care Medicine (69 citations) and Epidemiology (381 citations). Anna Conen has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Andrej Trampuž, Manuel Battegay, Christoph A. Fux, Ursula M. Flückiger, Laura Naëmi Walti, Adrian Ulrico Merlo, Peter Vajkoczy, Philipp Schüetz, Beat Müeller and Claudia Gregoriano. Their work appears in journals such as Clinical Infectious Diseases, Infection, Open Forum Infectious Diseases, The Lancet and Clinical Microbiology and Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact